ETF MANAGERS GROUP LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-24 1:59 pm Sale | 2022-08-23 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 206,489 4.950% | -160,015 (-43.66%) | Filing |
| 2022-02-14 3:55 pm Sale | 2022-02-11 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 366,505 8.780% | -108,174 (-22.79%) | Filing |
| 2021-06-01 1:22 pm Purchase | 2021-05-28 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 474,679 11.390% | 252,230 (+113.39%) | Filing |
| 2021-05-11 1:33 pm Purchase | 2021-05-10 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 222,449 5.340% | 22,537 (+11.27%) | Filing |
| 2021-03-17 1:07 pm Purchase | 2021-03-16 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ETF MANAGERS GROUP LLC | 199,911 4.800% | 4,867 (+2.50%) | Filing |